| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY.
When a patient with cancer develops a brain metastasis, death is usually imminent, but aggressive treatment in some patients with limited or no systemic disease yields long-term survival. In such patients, delayed deleterious effects of therapy are particularly tragic. We report 12 patients who developed delayed complications of whole brain radiotherapy (WBRT) given as sole treatment (4 patients) or in combination with surgical resection (8 patients). Within 5 to 36 months (median, 14) all patients developed progressive dementia, ataxia, and urinary incontinence causing severe disability in all and leading to death in 7. No patient had tumor recurrence when neurologic symptoms began. Cortical atrophy and hypodense white matter were identified by CT in all. Contrast-enhancing lesions were seen in 3 patients; 2 of the lesions yielded radionecrosis on biopsy. Autopsies on 2 patients revealed diffuse chronic edema of the hemispheric white matter in the absence of tumor recurrence. Corticosteroids and ventriculoperitoneal shunt offered significant but incomplete improvement in some patients. The total dose of WBRT was only 2,500 to 3,900 cGy, but daily fractions of 300 to 600 cGy were employed. We believe that these fractionation schedules, several of which are used commonly, predispose to delayed neurologic toxicity, and that more protracted schedules should be employed for the safe and efficacious treatment of good-risk patients with brain metastases. The incidence of WBRT-induced dementia was only 1.9 to 5.1% in the 2 populations reviewed here; however, this underestimates the incidence because only severely affected patients could be identified from chart review.
Address correspondence and reprint requests to Dr. DeAngelis, Department of Neurology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021.
Dr. DeAngelis is a recipient of an American Cancer Society Clinical Oncology Career Development Award.
Presented in part at the thirty-ninth annual meeting of the American Academy of Neurology, New York, NY, April 1987.
Received October 13, 1988. Accepted for publication in final form November 29, 1988.
This article has been cited by other articles:
|
|
 |
|
  K. Matsumoto, M. Ando, C. Yamauchi, C. Egawa, Y. Hamamoto, M. Kataoka, T. Shuto, K. Karasawa, M. Kurosumi, N. Kan, et al. Questionnaire Survey of Treatment Choice for Breast Cancer Patients with Brain Metastasis in Japan: Results of a Nationwide Survey by the Task Force of the Japanese Breast Cancer Society Jpn. J. Clin. Oncol., January 1, 2009; 39(1): 22 - 26. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J.B. Taphoorn Neurocognitive Effects of Radiotherapy ASCO Educational Book, January 1, 2009; 2009(1): 90 - 93. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Schiff and R. Cavaliere Role of Fractionated Radiotherapy and Radiosurgery in Newly Diagnosed Brain Metastases ASCO Educational Book, January 1, 2009; 2009(1): 95 - 99. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Dietrich, M. Monje, J. Wefel, and C. Meyers Clinical Patterns and Biological Correlates of Cognitive Dysfunction Associated with Cancer Therapy Oncologist, December 1, 2008; 13(12): 1285 - 1295. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Brandes, E. Franceschi, A. Tosoni, V. Blatt, A. Pession, G. Tallini, R. Bertorelle, S. Bartolini, F. Calbucci, A. Andreoli, et al. MGMT Promoter Methylation Status Can Predict the Incidence and Outcome of Pseudoprogression After Concomitant Radiochemotherapy in Newly Diagnosed Glioblastoma Patients J. Clin. Oncol., May 1, 2008; 26(13): 2192 - 2197. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Brandes, A. Tosoni, F. Spagnolli, G. Frezza, M. Leonardi, F. Calbucci, and E. Franceschi Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: Pitfalls in neurooncology Neuro-oncol, January 1, 2008; 10(3): 361 - 367. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. F. Eichler and J. S. Loeffler Multidisciplinary Management of Brain Metastases Oncologist, July 1, 2007; 12(7): 884 - 898. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Ewend, S. Brem, M. Gilbert, R. Goodkin, P. L. Penar, M. Varia, S. Cush, and L. A. Carey Treatment of Single Brain Metastasis with Resection, Intracavity Carmustine Polymer Wafers, and Radiation Therapy Is Safe and Provides Excellent Local Control Clin. Cancer Res., June 15, 2007; 13(12): 3637 - 3641. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Li, S. M. Bentzen, M. Renschler, and M. P. Mehta Regression After Whole-Brain Radiation Therapy for Brain Metastases Correlates With Survival and Improved Neurocognitive Function J. Clin. Oncol., April 1, 2007; 25(10): 1260 - 1266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. R. Patel and M. P. Mehta Targeted Therapy for Brain Metastases: Improving the Therapeutic Ratio Clin. Cancer Res., March 15, 2007; 13(6): 1675 - 1683. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. D. Brown, A. W. Jensen, S. J. Felten, K. V. Ballman, P. L. Schaefer, K. A. Jaeckle, J. H. Cerhan, and J. C. Buckner Detrimental Effects of Tumor Progression on Cognitive Function of Patients With High-Grade Glioma J. Clin. Oncol., December 1, 2006; 24(34): 5427 - 5433. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Aoyama, H. Shirato, M. Tago, K. Nakagawa, T. Toyoda, K. Hatano, M. Kenjyo, N. Oya, S. Hirota, H. Shioura, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA, June 7, 2006; 295(21): 2483 - 2491. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Raizer Radiosurgery and whole-brain radiation therapy for brain metastases: either or both as the optimal treatment. JAMA, June 7, 2006; 295(21): 2535 - 2536. [Full Text] [PDF]
|
|
|
|
|
|
F. F. Lang and M. R. Gilbert Diffusely Infiltrative Low-Grade Gliomas in Adults J. Clin. Oncol., March 10, 2006; 24(8): 1236 - 1245. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Vogelbaum and J. H. Suh Resectable Brain Metastases J. Clin. Oncol., March 10, 2006; 24(8): 1289 - 1294. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Khuntia, P. Brown, J. Li, and M. P. Mehta Whole-Brain Radiotherapy in the Management of Brain Metastasis J. Clin. Oncol., March 10, 2006; 24(8): 1295 - 1304. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Manon, A. O'Neill, J. Knisely, M. Werner-Wasik, H. M. Lazarus, H. Wagner, M. Gilbert, and M. Mehta Phase II Trial of Radiosurgery for One to Three Newly Diagnosed Brain Metastases From Renal Cell Carcinoma, Melanoma, and Sarcoma: An Eastern Cooperative Oncology Group Study (E 6397) J. Clin. Oncol., December 1, 2005; 23(34): 8870 - 8876. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. U. Lin, J. R. Bellon, and E. P. Winer CNS Metastases in Breast Cancer J. Clin. Oncol., September 1, 2004; 22(17): 3608 - 3617. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Grant Overview: brain tumour diagnosis and management/Royal College of Physicians guidelines J. Neurol. Neurosurg. Psychiatry, June 1, 2004; 75(suppl_2): ii18 - ii23. [Full Text] [PDF]
|
|
|
|
 |
|
 B. P. O'Neill Neurocognitive outcomes in primary CNS lymphoma (PCNSL) Neurology, February 24, 2004; 62(4): 532 - 533. [Full Text] [PDF]
|
|
|
|
|
|
R. Lai, L. E. Abrey, M. K. Rosenblum, and L. M. DeAngelis Treatment-induced leukoencephalopathy in primary CNS lymphoma: A clinical and autopsy study Neurology, February 10, 2004; 62(3): 451 - 456. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. T. Wong and A. Berkenblit The Role of Topotecan in the Treatment of Brain Metastases Oncologist, February 1, 2004; 9(1): 68 - 79. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. D. Brown, J. C. Buckner, J. H. Uhm, and E. G. Shaw The neurocognitive effects of radiation in adult low-grade glioma patients Neuro-oncol, July 1, 2003; 5(3): 161 - 167. [Abstract] [PDF]
|
|
|
|
|
|
P. D. Brown, J. C. Buckner, J. R. O'Fallon, N. L. Iturria, C. A. Brown, B. P. O'Neill, B. W. Scheithauer, R. P. Dinapoli, R. M. Arusell, W. J. Curran, et al. Effects of Radiotherapy on Cognitive Function in Patients With Low-Grade Glioma Measured by the Folstein Mini-Mental State Examination J. Clin. Oncol., July 1, 2003; 21(13): 2519 - 2524. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. J. Torres, A. J. Mundt, P. J. Sweeney, S. Llanes-Macy, L. Dunaway, M. Castillo, and R. L. Macdonald A longitudinal neuropsychological study of partial brain radiation in adults with brain tumors Neurology, April 8, 2003; 60(7): 1113 - 1118. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Meyers and K. R. Hess Multifaceted end points in brain tumor clinical trials: Cognitive deterioration precedes MRI progression Neuro-oncol, April 1, 2003; 5(2): 89 - 95. [Abstract] [PDF]
|
|
|
|
|
|
D. Antonadou, M. Paraskevaidis, G. Sarris, N. Coliarakis, I. Economou, P. Karageorgis, and N. Throuvalas Phase II Randomized Trial of Temozolomide and Concurrent Radiotherapy in Patients With Brain Metastases J. Clin. Oncol., September 1, 2002; 20(17): 3644 - 3650. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Armstrong, J. V. Hunter, G. E. Ledakis, B. Cohen, E. M. Tallent, B. H. Goldstein, Z. Tochner, R. Lustig, K. D. Judy, A. Pruitt, et al. Late cognitive and radiographic changes related to radiotherapy: Initial prospective findings Neurology, July 9, 2002; 59(1): 40 - 48. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Postma, M. Klein, C. C.P. Verstappen, J. E.C. Bromberg, M. Swennen, J. A. Langendijk, M. J.B. Taphoorn, P. Scheltens, B. J. Slotman, H. M. van der Ploeg, et al. Radiotherapy-induced cerebral abnormalities in patients with low-grade glioma Neurology, July 9, 2002; 59(1): 121 - 123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. D. A. Padula, B. McCormick, and D. H. Abramson Brain Necrosis After Enucleation, External Beam Cobalt Radiotherapy, and Systemic Chemotherapy for Retinoblastoma Arch Ophthalmol, January 1, 2002; 120(1): 98 - 99. [Full Text] [PDF]
|
|
|
|
|
|
O. Surma-aho, M. Niemela, J. Vilkki, M. Kouri, A. Brander, O. Salonen, A. Paetau, M. Kallio, J. Pyykkonen, LicPhil;, and J. Jaaskelainen Adverse long-term effects of brain radiotherapy in adult low-grade glioma patients Neurology, May 22, 2001; 56(10): 1285 - 1290. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. P. O'Neill, C.-H. Wang, J. R. O'Fallon, J. P. Colgan, J. D. Earle, R. L. Krigel, L. D. Brown, and W. J. McGinnis The consequences of treatment and disease in patients with primary CNS non-Hodgkin's lymphoma: Cognitive function and performance status Neuro-oncol, July 1, 1999; 1(3): 196 - 203. [Abstract] [PDF]
|
|
|
|
 |
|
 F. Noel, G. J. Gumin, U. Raju, and P. J. Tofilon Increased expression of prohormone convertase-2 in the irradiated rat brain FASEB J, December 1, 1998; 12(15): 1725 - 1730. [Abstract] [Full Text]
|
|
|
|
|
|
R. A. Patchell, P. A. Tibbs, W. F. Regine, R. J. Dempsey, M. Mohiuddin, R. J. Kryscio, W. R. Markesbery, K. A. Foon, and B. Young Postoperative Radiotherapy in the Treatment of Single Metastases to the Brain: A Randomized Trial JAMA, November 4, 1998; 280(17): 1485 - 1489. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Thiessen and L. M. DeAngelis Hydrocephalus in Radiation Leukoencephalopathy: Results of Ventriculoperitoneal Shunting Arch Neurol, May 1, 1998; 55(5): 705 - 710. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Duffey, G. Chari, N. E. F. Cartlidge, and P. J. Shaw Progressive Deterioration of Intellect and Motor Function Occurring Several Decades After Cranial Irradiation: A New Facet in the Clinical Spectrum of Radiation Encephalopathy Arch Neurol, August 1, 1996; 53(8): 814 - 818. [Abstract] [PDF]
|
|
|
|
|
|
P. L. Moots, R. J. Maciunas, D. R. Eisert, R. A. Parker, K. Laporte, and B. Abou-Khalil The Course of Seizure Disorders in Patients With Malignant Gliomas Arch Neurol, July 1, 1995; 52(7): 717 - 724. [Abstract] [PDF]
|
|
|
|
 |
|
 B. Movsas, B. S. Y. Li, J. S. Babb, B. L. Fowble, N. Nicolaou, and O. Gonen Quantifying Radiation Therapy-induced Brain Injury with Whole-Brain Proton MR Spectroscopy: Initial Observations Radiology, November 1, 2001; 221(2): 327 - 331. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
